Search

everythinglearnresearchcommunity

for

Search:↓

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Hair loss doesn't affect COVID-19 severity.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Women are more likely to have long-term post-COVID symptoms than men.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Eating disorders can cause skin problems, which may help with early diagnosis and treatment.

Poor nutrition can lead to skin diseases in hospitalized patients and should be quickly identified and treated.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Extra virgin olive oil may boost the immune system and help fight infections like COVID-19.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

More research is needed to understand sex and racial differences in long COVID.